Naltrexone
Alcohol dependence, Blockade of the effects of exogenously administered opioids
Indications
- Alcohol dependence
- Blockade of the effects of exogenously administered opioids
Adult dosing
- alcohol dependence: dose: 50; unit: mg; route: PO; interval: once daily; fixed: true; labelExcerpt: A dose of 50 mg once daily is recommended for most patients. The placebo-controlled studies that demonstrated the efficacy of naltrexone hydrochloride tablets as an adjunctive treatment of alcoholism used a dose regimen of naltrexone hydrochloride tablets 50 mg once daily for up to 12 weeks.
- opioid dependence initial: dose: 25; unit: mg; route: PO; interval: initial dose; fixed: true; labelExcerpt: Treatment should be initiated with an initial dose of 25 mg of naltrexone hydrochloride tablets.
- opioid dependence maintenance: dose: 50; unit: mg; route: PO; interval: once a day; fixed: true; labelExcerpt: If no withdrawal signs occur, the patient may be started on 50 mg a day thereafter. A dose of 50 mg once a day will produce adequate clinical blockade of the actions of parenterally administered opioids.
Pediatric dosing
- Consult pharmacy/current label
Renal adjustment
- Consult pharmacy/current label
Hepatic adjustment
- Consult pharmacy/current label
Contraindications
- Patients receiving opioid analgesics
- Patients currently dependent on opioids
- Patients in acute opioid withdrawal
- Failed naloxone challenge test
- History of sensitivity to naltrexone hydrochloride
Clinical pearls
- Patients must be opioid-free for 7 to 10 days prior to initiating therapy to avoid precipitated withdrawal.
- Consider prescribing an opioid overdose reversal agent (e.g., naloxone) due to increased risk of overdose upon relapse or discontinuation.
- The opioid blockade produced by naltrexone is surmountable by large doses of exogenous opioids, which is dangerous.
- Monitor for signs of opioid withdrawal after initiation, as these may require medical management.
Source and review
- DailyMed label (naltrexone hydrochloride), Set ID 3cbd0cad-7c56-ac0a-e063-6294a90a80e4, effective 2026-09-24. Last reviewed: 2026-11-11
RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties